Tribble’s homolog 3/glycogen synthase kinase-3β (TRIB3‒GSK-3β) interactions promote lung fibrosis and could be used as the potential therapeutic target (Liu et al., 2021). Here, TRIB3 is linked to pulmonary fibrosis.